全球非專利藥產業合作趨勢（2010年）：企業索引 是由出版商Espicom Business Intelligence在2010年10月所出版的。
這份英文市場調查報告書包含472 Pages 價格從美金1040起跳。
本報告為，為便利全球非專利藥市場中M&A候選及合作夥伴之選定，共刊載全球40國168間中型非專利藥生產商之企業數據，以下列摘要形式闡述。
刊載內容
刊載地區
Abstract
META Description
Identify merger, acquisition and partner candidates in the rapidly changing
global generics market...
Consolidation and collaboration runs throughout the generic industry. Here' s
just a taste of the acquisitions, controlling investments and deals reported
recently...
- URL Pharma acquire manufacturing assets of PharmPro
- Luitpold Pharma acquires Pharmaforce
- Hi-Tech Pharmacal acquires product line from Blaine Company
- Aspen Pharmacare acquires Sigma' s pharmaceutical division
- Sun Pharmaceuticals' long expected acquisition of Taro Pharmaceuticals
- Sandoz acquires Ebewe Pharmaceuticals
- GSK acquires Stiefel
- Strides Arcolab acquires Ascent Pharmahealth
- sanofi-aventis form Japanese joint venture with Nichi-Iko
- Adcock-Ingram acquires Ghanaian manufacturer Ayrton
- Cephalon acquires Mepha
- Strategic partnering
In addition to outright purchase, strategic partnering or the acquisition of
specific drug assets is on the rise as companies seek to bring lower costs and
focus to their portfolios. With business cycles growing shorter and shorter,
market entry is quicker, more reliable and less risky through acquisition and
partnering.
The fundamental market drivers are sound
In addition to ongoing expansion, there are other drivers which are causing
the generic companies to consider the future:
Over the next 5 years a number of blockbuster pharmaceutical products such as
Lipitor, Cozaar, Lovenox, Plavix, Cymbalta and Seroquel will be losing patent
protection. The number of biologics coming into the remit of generic companies
is increasing, raising interest in companies with biosimilars production
capability. The branded industry' s response
The branded industry continues to vigorously protect its IP and maximise the
lifetime value of its products. While legal initiatives will remain a key
weapon there will also be commercial responses such as issuing early branded
generics, collaborative working with a limited number of generic producers,
new formulations or combination products.
Identify new business opportunities and assess risk
For everyone needing to evaluate the generic industry' s competitive landscape,
this thoroughly-researched and expanded 3rd Edition of Partnering in the
Global Generics Industry 2010: A guide to companies (published October 2010)
is essential reading. In 450 information-packed pages this completely revised
edition references 168 generics companies operating in 40 markets around the
world.
- Africa/Middle East
- EIPICo Egypt
- Dexcel Pharma Israel
- Taro Pharmaceutical Industries Israel
- Hikma Jordan
- Regal Pharmaceuticals Kenya
- Tabuk Pharmaceutical Manufacturing Saudi Arabia
- Adcock Ingram South Africa
- Cipla Medpro South Africa
- Asia/Pacific
- Ascent Pharmahealth Australia
- Australian Pharmaceutical Industries Australia
- Hamilton Laboratories Australia
- Sigma Pharmaceuticals Australia
- Beximco Pharmaceuticals Bangladesh
- China Pharma Holdings China
- Alembic India
- Alkem Laboratories India
- Biocon India
- Emcure Pharmaceuticals India
- Gland Pharma India
- Glenmark Pharmaceuticals India
- Hetero Drugs India
- Indoco Remedies India
- JB Chemicals & Pharmaceuticals India
- Jubilant Organosys India
- Natco Pharma India
- Orchid Chemicals & Pharmaceuticals India
- Strides Arcolab India
- Torrent Pharmaceuticals India
- USV India
- Kimia Indonesia
- Nichi-iko Pharmaceutical Japan
- Towa Pharmaceutical Japan
- CCM Pharmaceuticals Malaysia
- Inno Biologics Malaysia
- CCL Pakistan
- Dr Raza Pharma Pakistan
- Epla Labs Pakistan
- Highnoon Laboratories Pakistan
- Abdi Ibrahim Turkey
- Bilim Pharmaceuticals Turkey
- EastPharma Turkey
- Mustafa Nevzat Pharmaceuticals Turkey
- Europe
- Ebewe Pharma Austria
- Sopharma Bulgaria
- Unipharm Bulgaria
- Belupo Croatia
- Alternova Denmark
- Orifarm Denmark
- Biogaran France
- Consilient Health Ireland
- Reliance GeneMedix Ireland
- Eurand Italy
- Grindeks Latvia
- Sanitas Lithuania
- Hovione FarmaCiencia Portugal
- Antibiotice Romania
- Europharm Romania
- Akrikhin Russia
- Bryntsalov Russia
- Erka Farm Russia
- Farmacon Russia
- Pharmstandard Russia
- Veropharm Russia
- Biotika Slovakia
- Combino Pharm Spain
- Invent Farma Group Spain
- Laboratorios Cinfa Spain
- Acino Pharma Switzerland
- Azad Switzerland
- Helvepharm Switzerland
- Mepha Pharma Switzerland
- Spirig Switzerland
- Streuli Switzerland
- Goldshield Group UK
- Kent Pharmaceuticals UK
- ProStrakan UK
- Rosemont Pharmaceutical UK
- North America
- Labopharm Canada
- Pharmascience Canada
- Akorn USA
- Alovgen USA
- Amneal Pharmaceuticals USA
- Amphastar Pharmaceuticals USA
- Anchen Pharmaceuticals USA
- APP Pharmaceuticals USA
- Banner Pharmacaps USA
- Bedford Laboratories USA
- Bio-Nucleonics USA
- Boca Pharmacal USA
- Breckenridge Pharma USA
- Caraco Pharmaceutical Laboratories USA
- Carolina Medical Products Company USA
- Cedar Pharmaceuticals USA
- Cephazone Pharma USA
- CorePharma USA
- Cypress Pharmaceutical USA
- Ferndale Laboratories USA
- Fleming Pharmaceuticals USA
- Fougera USA
- G&W Laboratories USA
- GeneraMedix USA
- Hanford Manufacturing USA
- Harmony Labs USA
- Heritage Pharmaceuticals USA
- Hi-Tech Pharmacal USA
- Indicus Pharmaceuticals USA
- InvaGen Pharmaceuticals USA
- Kremers-Urban (KUDCo) USA
- KV Pharmaceutical USA
- KVK-Tech USA
- Luitpold Pharmaceuticals USA
- Lyne Laboratories USA
- Mallinckrodt USA
- Mikart USA
- Neil Laboratories USA
- Nephron Pharmaceuticals USA
- Paddock Laboratories USA
- Pharmaceutical Associates USA
- PharmaForce USA
- Prasco USA
- Prometheus Laboratories USA
- Roxane Laboratories USA
- RxElite Holdings USA
- Silarx Pharmaceuticals USA
- Spear Pharmaceuticals USA
- Stasun Pharmaceuticals USA
- Stiefel USA
- SuperGen USA
- ThePharmaNetwork USA
- Three Rivers Pharmaceuticals USA
- Tris Pharma USA
- URL Pharma USA
- Upsher-Smith Laboratories USA
- VersaPharm USA
- Vista Pharmaceuticals USA
- VistaPharm USA
- X-GEN Pharmaceuticals USA
- South America
- Osmotica Pharmaceutical Argentina
- Ache Brazil
- Americano Brazil
- Biolab Brazil
- Cimed Brazil
- Cristalia Brazil
- EMS-Sigma Brazil
- Eurofarma Brazil
- LAFEPE Brazil
- Libbs Farmaceutica Brazil
- Medley Brazil
- Prati-Donaduzzi Brazil
- Andromaco Chile
- Bestpharma Chile
- Biosano Chile
- Maver Chile
- Mintlab Chile
- Ecar Colombia
- Genfar Colombia
- La Sante Colombia
- Lafrancol Colombia
- Laboratorios Kendrick Mexico
- Laboratorios Silanes Mexico
- Farmindustria Peru
- Induquimica Peru
- Infarmasa Peru
- Calox Internacional Venezuela
- Cofasa Venezuela
- Kimiceg Venezuela
- Leti Venezuela
- Meyer Venezuela
More Information...
Unbeatable coverage
For each company, where available or appropriate, the report provides...
BACKGROUND
A summary of the company' s foundation and main business interests
PRODUCT RANGE
Details of ANDAs approved or products represented
FINANCIAL
Financial performance or funding data
STRATEGIC ALLIANCES
Details of significant marketing and supply agreements
CONTACT INFORMATION
Use this report to...
- Identify commercial partners
- Understand the developing generic industry in key markets worldwide
- Profile the competitive environment in the increasingly important
medium-sized company sector
- Seek out companies manufacturing/marketing similar product lines
- Assess the investment potential of these developing companies
Table of Contents
Introduction
Argentina
Osmotica Pharmaceutical
- Background
- Products
- Contact Details
Australia
Ascent Pharmahealth
- Background
- Products
- Financials
- Major Developments
- Contact Details
Australian Pharmaceutical Industries
- Background
- Financials
- Major Developments
- Contact Details
Hamilton Laboratories
- Background
- Products
- Contact Details
Sigma Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
Austria
Ebewe Pharma
- Background
- Products
- Financials
- Major Developments
- Contact Details
Bangladesh
Beximco Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
Brazil
Aché
- Background
- Products
- Financials
- Major Developments
- Contact Details
Americano
- Background
- Products
- Financials
- Contact Details
Biolab
- Background
- Products
- Financials
- Contact Details
Cimed
- Background
- Products
- Financials
- Contact Details
Cristalia
- Background
- Products
- Financials
- Contact Details
EMS-Sigma
- Background
- Products
- Financials
- Contact Details
Eurofarma
- Background
- Major Developments
- Contact Details
LAFEPE
- Background
- Products
- Contact Details
Libbs Farmaceutica
- Background
- Products
- Financials
- Major Developments
- Contact Details
Medley
- Background
- Products
- Financials
- Major Developments
- Contact Details
Prati-Donaduzzi
- Background
- Products
- Financials
- Contact Details
Bulgaria
Sopharma
- Background
- Products
- Financials
- Contact Details
Unipharm
- Background
- Contact Details
Canada
Labopharm
- Background
- Products
- Financials
- Major Developments
- Contact Details
Pharmascience
- Background
- Products
- Major Developments
- Contact Details
Chile
Andromaco
- Background
- Products
- Financials
- Major Developments
- Contact Details
Bestpharma
- Background
- Products
- Contact Details
Biosano
- Background
- Products
- Financials
- Contact Details
Maver
- Background
- Contact Details
Mintlab
- Background
- Contact Details
China
China Pharma Holdings
- Background
- Products
- Financials
- Contact Details
Colombia
Ecar
- Background
- Contact details
Genfar
- Background
- Contact Details
La Santé
- Background
- Contact Details
Lafrancol
- Background
- Contact Details
Croatia
Belupo
- Background
- Products
- Contact Details
Denmark
Alternova
- Background
- Products
- Contact Details
Orifarm
- Background
- Products
- Contact Details
Egypt
EIPICo
- Background
- Products
- Contact Details
France
Biogaran
- Background
- Contact Details
India
Alembic
- Background
- Products
- Financials
- Major Developments
- Contact Details
Alkem Laboratories
- Background
- Products
- Major Developments
- Contact Details
Biocon
- Background
- Products
- Financials
- Major Developments
- Contact Details
Emcure Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Gland Pharma
- Background
- Products
- Contact Details
Glenmark Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
Hetero Drugs
- Background
- Products
- Major Developments
- Contact Details
Indoco Remedies
- Background
- Products
- Financials
- Major Developments
- Contact Details
JB Chemicals & Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Mergers, Acquisitions and Agreements
- Contact Details
Jubilant Organosys
- Background
- Products
- Financials
- Major Developments
- Contact Details
Natco Pharma
- Background
- Products
- Financials
- Major Developments
- Contact Details
Orchid Chemicals & Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
Strides Arcolab
- Background
- Products
- Financials
- Major Developments
- Contact Details
Torrent Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
USV
- Background
- Products
- Contact Details
Indonesia
Kimia
- Background
- Contact Details
Ireland
Consilient Health
- Background
- Products
- Contact Details
Reliance GeneMedix
- Background
- Products
- Financials
- Major Developments
- Contact Details
Israel
Dexcel Pharma
- Background
- Products
- Major Developments
- Contact Details
Taro Pharmaceutical Industries
- Background
- Products
- Financials
- Major Developments
- Contact Details
Italy
Eurand
- Background
- Products
- Financials
- Major Developments
- Contact Details
Japan
Nichi-iko Pharmaceutical
- Background
- Financials
- Major Developments
- Contact Details
Towa Pharmaceutical
- Background
- Products
- Financials
- Major developments
- Contact Details
Jordan
Hikma
- Background
- Products
- Financials
- Major Developments
- Contact Details
Kenya
Regal Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Latvia
Grindeks
- Background
- Products
- Financials
- Major Developments
- Contact Details
Lithuania
Sanitas
- Background
- Products
- Financials
- Major Developments
- Contact Details
Malaysia
CCM Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
Inno Biologics
- Background
- Products
- Contact Details
Mexico
Laboratorios Kendrick
- Background
- Contact Details
Laboratorios Silanes
- Background
- Contact Details
Pakistan
CCL
- Background
- Contact Details
Dr. Raza Pharma
- Background
- Contact Details
Epla Labs
- Background
- Products
- Contact Details
Highnoon Laboratories
- Background
- Products
- Financials
- Contact Details
Peru
Farmindustria
- Background
- Contact Details
Induquimica
- Background
- Products
- Contact Details
Infarmasa
- Background
- Financials
- Contact Details
Portugal
Hovione FarmaCiencia
- Background
- Products
- Financials
- Major Developments
- Contact Details
Romania
Antibiotice
- Background
- Products
- Financials
- Contact Details
Europharm
- Background
- Contact Details
Russia
Akrikhin
- Background
- Products
- Financials
- Contact Details
Bryntsalov A
- Background
- Contact Details
Erka Farm
Farmacon
- Background
- Contact Details
Pharmstandard
- Background
- Products
- Financials
- Major Developments
- Contact Details
Veropharm
- Background
- Financials
- Contact Details
Saudi Arabia
Tabuk Pharmaceutical Manufacturing
- Background
- Contact Details
Slovakia
Biotika
- Background
- Financials
- Contact Details
South Africa
Adcock Ingram
- Background
- Products
- Financials
- Major Developments
- Contact Details
Cipla Medpro
- Background
- Products
- Financials
- Major Developments
- Contact Details
Spain
Combino Pharm
- Background
- Products
- Major Developments
- Contact Details
Invent Farma Group
- Background
- Products
- Major Developments
- Contact Details
Laboratorios Cinfa
- Background
- Products
- Financials
- Major Developments
- Contact Details
Switzerland
Acino Pharma
- Background
- Products
- Financials
- Major Developments
- Contact Details
Azad
- Background
- Products
- Major Developments
- Contact Details
Helvepharm
- Background
- Contact Details
Mepha Pharma
- Background
- Financials
- Contact Details
Spirig
- Background
- Products
- Financials
- Contact Details
Streuli
- Background
- Contact Details
Turkey
Abdi Ibrahim
- Background
- Products
- Major Developments
- Contact Details
Bilim Pharmaceuticals
- Background
- Products
- Contact Details
EastPharma
- Background
- Products
- Financials
- Contact Details
Mustafa Nevzat Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
UK
Goldshield Group
- Background
- Products
- Financials
- Major Developments
- Contact Details
Kent Pharmaceuticals
- Background
- Financials
- Major Developments
- Contact Details
ProStrakan
- Background
- Products
- Financials
- Major Developments
- Contact Details
Rosemont Pharmaceutical
- Background
- Products
- Financials
- Major Developments
- Contact Details
USA
Akorn
- Background
- Products
- Financials
- Major Developments
- Contact Details
Alovgen
- Background
- Products
- Major Developments
- Contact Details
Amneal Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Amphastar Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Anchen Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
APP Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Banner Pharmacaps
- Background
- Products
- Major Developments
- Contact Details
Bedford Laboratories
- Background
- Products
- Major Developments
- Contact Details
Bio-Nucleonics
- Background
- Products
- Contact Details
Boca Pharmacal
- Background
- Products
- Contact Details
Breckenridge Pharma
- Background
- Products
- Major Developments
- Contact Details
Caraco Pharmaceutical Laboratories
- Background
- Products
- Financials
- Major Developments
- Contact Details
Carolina Medical Products Company
- Background
- Products
- Contact Details
Cedar Pharmaceuticals
- Background
- Products
- Contact Details
Cephazone Pharma
- Background
- Products
- Contact Details
CorePharma
- Background
- Products
- Major Developments
- Contact Details
Cypress Pharmaceutical
- Background
- Products
- Major Developments
- Contact Details
Ferndale Laboratories
- Background
- Products
- Major Developments
- Contact Details
Fleming Pharmaceuticals
- Background
- Products
- Contact Details
Fougera
- Background
- Products
- Major Developments
- Contact Details
G&W Laboratories
- Background
- Products
- Contact Details
GeneraMedix
- Background
- Products
- Major Developments
- Contact Details
Hanford Manufacturing
- Background
- Products
- Major Developments
- Contact Details
Harmony Labs
- Background
- Products
- Contact Details
Heritage Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Hi-Tech Pharmacal
- Background
- Products
- Financials
- Major Developments
- Contact Details
Indicus Pharmaceuticals
- Background
- Products
- Contact Details
InvaGen Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Kremers-Urban (KUDCo)
- Background
- Products
- Major Developments
- Contact Details
KV Pharmaceutical
- Background
- Products
- Financials
- Major Developments
- Contact Details
KVK-Tech
- Background
- Products
- Contact Details
Luitpold Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Lyne Laboratories
- Background
- Products
- Contact Details
Mallinckrodt
- Background
- Products
- Major Developments
- Contact Details
Mikart
- Background
- Products
- Contact Details
Neil Laboratories
- Background
- Products
- Contact Details
Nephron Pharmaceuticals
- Background
- Products
- Contact Details
Paddock Laboratories
- Background
- Products
- Major Developments
- Contact Details
Pharmaceutical Associates
- Background
- Products
- Contact Details
PharmaForce
- Background
- Products
- Major Developments
- Contact Details
Prasco
- Background
- Products
- Major Developments
- Contact Details
Prometheus Laboratories
- Background
- Products
- Contact Details
Roxane Laboratories
- Background
- Products
- Major Developments
- Contact Details
RxElite Holdings
- Background
- Products
- Major Developments
- Contact Details
Silarx Pharmaceuticals
- Background
- Products
- Contact Details
Spear Pharmaceuticals
- Background
- Products
- Contact Details
Stason Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Stiefel
- Background
- Products
- Major Developments
- Contact Details
SuperGen
- Background
- Products
- Financials
- Major Developments
- Contact Details
ThePharmaNetwork
- Background
- Products
- Contact Details
Three Rivers Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Tris Pharma
- Background
- Major Developments
- Contact Details
URL Pharma
- Background
- Products
- Major Developments
- Contact Details
Upsher-Smith Laboratories
- Background
- Products
- Major Developments
- Contact Details
VersaPharm
- Background
- Products
- Contact Details
Vista Pharmaceuticals
- Background
- Products
- Contact Details
VistaPharm
- Background
- Products
- Contact Details
X-GEN Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Venezuela
Calox Internacional
- Background
- Contact Details
Cofasa
- Background
- Contact Details
Kimiceg
- Background
- Contact Details
Leti
- Background
- Contact Details
Meyer
- Background
- Contact Details
INDEX OF TABLES
- Companies in the report by country of origin
- Osmotica Pharmaceutical ANDA Approvals, 2002 - June 2010
- Ascent Pharmahealth: consolidated fiscal year results in A$000s
- Australian Pharmaceutical Industries: consolidated fiscal year results in
A$000s
- Sigma Pharmaceuticals: fiscal year results in A$ millions
- Ebewe Pharma ANDA Approvals, 2002-09
- Beximco Pharmaceuticals: fiscal year results, in BDT000s
- Cimed: Sales, 2004 - 2007
- LAFEPE: Product Lines
- Libbs Farmaceutica: Pharmaceutical Sales, 2000 - 2006
- Medley: International Agreements, 1992 - 2005
- Medley: pharmacy sales by value in US$ millions
- Medley: generic sales by volume
- Sopharma: Financial Data, in Leva 000s
- Labopharm: fiscal year results, in C$000s
- Andromaco: Financial Results, 2000 - 2007
- Biosano: Product Portfolio
- Alembic: manufacturing facilities
- Alembic ANDA Approvals, 2002 - June 2010
- Alembic: Financial Results, in Rs millions
- Alkem Laboratories ANDA Approvals, 2002 - June 2010
- Biocon: Consolidated Financial Results, in Rs millions
- Emcure Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Gland Pharma ANDA Approvals, 2002 - June 2010
- Glenmark Pharmaceuticals / Glenmark Generics ANDA Approvals, January 2002
- June 2010
- Glenmark Pharmaceuticals: consolidated financial results in Rs millions
- Glenmark Pharmaceuticals: consolidated financial results by business in Rs
millions
- Hetero Drugs ANDA Approvals, 2002 - June 2010
- Indoco Remedies: Financial Results (Rs millions)
- Indoco Remedies: Financial Results (US$ millions)
- Unique Pharmaceutical Laboratories ANDA Approvals, 2002 - June 2010
- JB Chemicals & Pharmaceuticals: Financial Results, in Rs millions
- JB Chemicals & Pharmaceuticals: Financial Results, in US$ millions
- Trigen Laboratories / Cadista Pharmaceuticals / Jubilant Pharmaceuticals
ANDA Approvals, January 2002 June 2010
- Jubilant Organosys: standalone financial results, in Rs millions
- Natco Pharma ANDA Approvals, January 2002 - June 2010
- Natco Pharma: standalone financial results in Rs millions
- Orchid Healthcare ANDA Approvals, January 2002 - June 2010
- Orchid Chemicals & Pharmaceuticals: fiscal year results in Rs millions
- Strides Arcolab ANDA Approvals, January 2002 - June 2010
- Akorn-Strides ANDA Approvals, January 2002 - June 2010
- Sagent-Strides ANDA Approvals, January 2002 - June 2010
- Strides Arcolab: consolidated fiscal year results in Rs millions
- Torrent Pharmaceuticals ANDA Approvals, January 2002 - June 2010
- Torrent Pharmaceuticals: consolidated financial results, in Rs millions
- Reliance GeneMedix: financial results, in euro 000s
- Dexcel ANDA Approvals, January 2002 - June 2010
- Taro Pharmaceutical Industries ANDA Approvals, January 2002 - June 2010
- Taro Pharmaceutical Industries: financial results, in US$000s
- Taro Pharmaceutical Industries: sales by location, in US$000s
- Taro Pharmaceutical Industries: preliminary financial results, in US$000s
- Eurand ANDA Approvals, January 2002 - June 2010
- Eurand: consolidated financial results, in euro 000s
- Nichi-Iko: Medium Term Business Plan Goals (¥ millions)
- Towa Pharmaceutical: Fiscal Year Sales, in yen millions
- Hikma Pharmaceuticals ANDA Approvals, January 2002 - June 2010
- West-Ward ANDA Approvals, January 2002 - June 2010
- Hikma: financial results, in US$000s
- Hikma: financial results by region, in US$000s
- Grindeks Group: financial results, in LVL000s
- Grindeks Group: sales by location, in LVL000s
- Sanitas: Group Financial Results, in LTL000s
- Sanitas: Selected Financial Results by Region, in LTL000s
- CCM: Group Financial Results, in RM000s
- Antibiotice: Financial Results, 2002 - 2007
- Pharmstandard: production by facility, 2008
- Pharmstandard: financial results, 2004 - 2008 (R millions)
- Pharmstandard: pharmaceutical sales, 2007 - 2008
- Pharmstandard: top 10 OTCs, 2007 - 2008
- Adcock Ingram: Fiscal Year Results, in R000s
- Cipla Medpro: Group Financial Results (R000s)
- EastPharma: Consolidated Financial Results, in US$000s
- Goldshield: Financial Results, 2003 - 2009 (£000s)
- Goldshield: Sales by Region, 2006 - 2009 (£000s)
- Goldshield: Selected Sales by Segment, 2006 - 2009 (£000s)
- ProStrakan: Consolidated Financial Results, in £ millions
- ProStrakan: Selected Consolidated Financial Results by Destination, in
£ millions
- Akorn ANDA Approvals, 2002 - June 2010
- Akorn-Strides ANDA Approvals, 2002 - June 2010
- Akorn: Financial Results in US$000s
- Amneal Pharmaceuticals ANDA Approvals, 2006 - June 2010
- Interpharm ANDA Approvals, 2002 - 2008
- Amphastar Pharmaceuticals ANDA Approvals, 2002 - June 2010
- International Medication Systems ANDA Approvals, 2002 - June 2010
- Anchen Pharmaceuticals ANDA Approvals, 2002 - June 2010
- American Pharmaceutical Partners ANDA Approvals, 2002 - 2006
- Abraxis ANDA Approvals, 2006 - 2008
- APP Pharmaceuticals ANDA Approvals, 2008 - June 2010
- Banner Pharmacaps ANDA Approvals, 2002 - June 2010
- Bedford Laboratories ANDA Approvals, 2002 - June 2010
- Ben Venue Laboratories ANDA Approvals, 2002 - June 2010
- Bio-Nucleonics ANDA Approvals, 2002 - June 2010
- Boca Pharmacal ANDA Approvals, 2002 - June 2010
- Breckenridge Pharmaceutical ANDA Approvals, 2002 - June 2010
- Caraco Pharmaceutical Laboratories ANDA Approvals, 2002 - June 2010
- Caraco Pharmaceutical Laboratories: Financial Results, FY2005 - FY2009
(US$000s)
- Carolina Medical Products ANDA Approvals, 2002 - June 2010
- Cedar Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Cephazone Pharma ANDA Approvals, 2002 - June 2010
- CorePharma ANDA Approvals, 2002 - June 2010
- Cypress Pharmaceutical ANDA Approvals, 2002 - June 2010
- Ferndale Laboratories ANDA Approvals, 2002 - June 2010
- Fleming & Company Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Altana ANDA Approvals, 2002 - June 2010
- Nycomed ANDA Approvals, 2002 - June 2010
- G&W Laboratories ANDA Approvals, 2002 - June 2010
- GeneraMedix ANDA Approvals, 2002 - June 2010
- Hanford Manufacturing ANDA Approvals, 2002 - June 2010
- Harmony Labs ANDA Approvals, 2002 - June 2010
- Hi-Tech Pharmacal ANDA Approvals, 2002 - June 2010
- Hi-Tech Pharmacal: Consolidated Fiscal Year Results, in US$ millions)
- Indicus Pharmaceuticals ANDA Approvals, 2002 - June 2010
- InvaGen Pharmaceuticals ANDA Approvals, 2002 - June 2010
- KUDCo ANDA Approvals, 2002 - June 2010
- KV Pharmaceuticals / Ethex ANDA Approvals, 2002 - June 2010
- KV Pharmaceutical: Financial Results, in US$ millions
- KVK-Tech ANDA Approvals, 2002 - June 2010
- Luitpold Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Lyne Laboratories ANDA Approvals, 2002 - June 2010
- Mallinckrodt ANDA Approvals, 20002 - June 2010
- Mikart ANDA Approvals, 2002 - June 2010
- Neil Laboratories ANDA Approvals, 2002 - June 2010
- Nephron Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Paddock Laboratories ANDA Approvals, 2002 - June 2010
- Pharmaceutical Associates ANDA Approvals, 2002 - June 2010
- PharmaForce ANDA Approvals, 2002 - June 2010
- Prometheus Laboratories ANDA Approvals, 2002 - June 2010
- Roxane Laboratories ANDA Approvals, 2002 - June 2010
- RxElite ANDA Approvals, 2002 - June 2010
- Silarx Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Spear Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Stason Pharmaceuticals ANDA Approvals, 2002 - June 2010
- Stiefel ANDA Approvals, 2002 - June 2010
- SuperGen ANDA Approvals, 2002 - June 2010
- SuperGen: Financial Results, in US$ millions
- ThePharmaNetwork ANDA Approvals, 2002 - June 2010
- Three Rivers ANDA Approvals, 2002 - June 2010
- Mutual Pharmaceutical Company ANDA Approvals, 2002 - June 2010
- Upsher-Smith Laboratories ANDA Approvals, 2002 - June 2010
- VersaPharm ANDA Approvals, 2002 - June 2010
- Covenant Pharma ANDA Approvals, 2002 - June 2010
- Vista Pharmaceuticals ANDA Approvals, 2002 - June 2010
- VistaPharm ANDA Approvals, 2002 - June 2010
- X-GEN Pharmaceuticals ANDA Approvals, 2002 - June 2010
|
